Pulmonary hypertension encompasses a range of conditions directly or indirectly leading to
elevated pressures within the pulmonary arteries. Five main groups of pulmonary …

In patients with sarcoidosis, the development of pulmonary hypertension is associated with
significant morbidity and mortality. The global prevalence of sarcoidosis-associated …

Pulmonary vascular involvement is a common complication in sarcoidosis, particularly in
advanced disease. 1 The mechanisms leading to the development of pulmonary …

Pulmonary sarcoidosis is the most common interstitial lung disease (ILD), especially in
middle-aged patients. 1, 2 Because of its heterogeneous onset and manifestations, the initial …

Sarcoidosis, an enigmatic disease with unknown etiology, is characterized by inflammation
and the potential involvement of various organs, predominantly the lungs and intrathoracic …

Although sarcoidosis is generally regarded as a benign condition, approximately 20–30% of
patients will develop a chronic and progressive disease. Advanced pulmonary fibrotic …

Sarcoidosis-associated pulmonary hypertension (SAPH) is a very severe complication of the
disease, largely impacting its morbidity and being one of its strongest predictors of mortality …

Background/Objectives: Pulmonary hypertension (PH) often accompanies chronic lung
diseases. Several chronic lung diseases with PH portends unfavorable outcomes. We …

In this issue of Clinics in Chest Medicine, guest editors Drs. Robert P. Baughman, Elyse E.
Lower, and Marc A. Judson bring their considerable expertise to the topic of Sarcoidosis …